Stress vs Androgenetic Hair Loss: How to Tell Them Apart
Written by the Balding AI Editorial Team · medically reviewed by Dr. Nga Nguyen (Dermatologist) · grounded in published clinical guidelines (AAD, NHS). This guide supports tracking and informed clinician conversations and is not medical advice or diagnosis.
Decision Framework
Use one comparison standard before you switch, stack, or commit
This format turns side-by-side comparisons into a cleaner choice by forcing one question, one evidence standard, and one checkpoint window before you act.
Best for readers who need one cleaner next step instead of another round of anxious comparison.
What this guide helps you decide
Run a 12 week structured protocol to separate stress-induced telogen effluvium from androgenetic alopecia using pattern, pull test, photo, and lab evidence
Read this first if you want one clearer answer instead of another loop of broad browsing.
Best fit for this stage
Best for readers who need one cleaner next step instead of another round of anxious comparison.
Stay oriented while you read
Use this reading map to jump straight to the section you need now, or follow it top to bottom if you want the full logic.
Key Takeaways
- Telogen effluvium is diffuse across the whole scalp and almost always lags a clear trigger by 2 to 4 months, while androgenetic alopecia is patterned (hairline, temples, crown in men; midline part widening in women) and progresses slowly over years.
- A positive hair pull test (more than about 10 percent of pulled hairs come out) across multiple zones supports active telogen effluvium, but a negative pull does not rule out androgenetic alopecia.
- Photo comparisons across 12 weeks under matched lighting and angles distinguish a reversible shed (density returns once the trigger clears) from a progressive miniaturization pattern (density does not return without treatment).
- Bloodwork for ferritin, 25-hydroxyvitamin D, TSH, and a basic CBC catches the reversible drivers that mimic androgenetic decline and lets you avoid mis-attributing a shed to genetic balding.
- If pattern and photo evidence point to androgenetic alopecia, the timer matters: starting finasteride or minoxidil during a measurable miniaturization phase produces a stronger 12 month outcome than waiting for visible bald patches.
Jump to sections
Two very different hair loss processes can both feel the same in the bathroom mirror: more hair on the brush, a wider part, and a worry that something is starting that will not stop. Stress-induced telogen effluvium and androgenetic alopecia are biologically distinct, respond to different treatments, and have very different prognoses. Telling them apart with structured evidence (not vibes) is the single most useful thing you can do in the first 12 weeks of a hair concern.
This guide covers the pattern, pull test, photo cadence, and lab workup needed to separate the two, and what to do once the picture becomes clearer.
Tell a stress shed apart from a pattern in 12 weeks of clean photos
BaldingAI runs a fixed-angle monthly photo record so a reversible shed and a progressive pattern look different on a timeline instead of being argued from memory.
Use the BaldingAI hair tracking app to save one baseline session now, compare monthly checkpoints later, and keep one clear record for your next treatment or dermatologist decision.
Two biologies that share one symptom
Telogen effluvium is a synchronized shift of follicles into the resting phase, typically triggered by a physiological stressor (severe illness, surgery, high fever, rapid weight loss, childbirth, major emotional stress, certain medications, iron or vitamin D deficiency, thyroid swings). The trigger acts at one point in time, the shedding shows up 2 to 4 months later as a diffuse increase across the entire scalp, and recovery starts once the trigger is removed, with regrowth visible from month 4 to 6 onward. The reference summary is Headington 1993, Archives of Dermatology, "Telogen effluvium: new concepts and review".
Androgenetic alopecia is a genetically programmed sensitivity of certain follicles to dihydrotestosterone (DHT). Affected follicles miniaturize over years: each cycle, the hair returns thinner, shorter, and less pigmented, eventually becoming vellus and then absent. In men the pattern is hairline recession, temple thinning, and crown thinning (Norwood scale). In women it is most often a widening central part (Ludwig scale) with preserved frontal hairline. The reference review is Olsen et al. 2005, Journal of the American Academy of Dermatology.
Side by side: how they actually present
| Feature | Telogen effluvium | Androgenetic alopecia |
|---|---|---|
| Onset | Sudden, 2 to 4 months after a clear trigger | Gradual over months to years |
| Distribution | Diffuse across whole scalp | Patterned (hairline/temples/crown or central part) |
| Pull test | Positive in multiple zones during active phase | Usually negative outside the affected zones |
| Hair caliber | Normal terminal hairs lost in higher numbers | Mixed caliber: thinning, shortened, and vellus hairs in affected zones |
| Trichoscopy | Empty follicular units possible, upright regrowth visible later | More than 20 percent hair diameter variability, single-hair units, perifollicular pigmentation |
| Trajectory at month 6 to 12 | Density returns once trigger clears | Density does not return without treatment |
The two can coexist. A common pattern in 30 to 50 year old women is mild background female pattern hair loss that becomes visible after a stress-related telogen effluvium unmasks it. Treating only the stress side leaves the slow miniaturization untreated. Treating only the pattern side ignores the trigger that is still firing. The point of a 12 week protocol is to see both layers clearly.
Step 1: map the trigger window
Write down the last 6 months in a single timeline. Look specifically for events 2 to 4 months before the shedding started: a high fever, COVID infection, surgery, anesthesia, major weight change, restrictive diet, postpartum month 3 to 6, sustained sleep loss, a clear emotional stress peak, or a medication start or stop (antidepressants, retinoids, beta blockers, anticoagulants).
A clear trigger window strongly supports telogen effluvium and shifts the expected timeline: shedding usually peaks in the first 6 to 8 weeks of the visible phase, then slows by month 4 to 6 with regrowth following.
Step 2: do a clean home pull test
The hair pull test is simple and informative if you run it consistently. On a wash-free day (no shampoo for 24 hours), grasp about 60 hairs near the scalp between thumb and forefinger and apply gentle traction outward. Repeat at the vertex, both temples, the central part, and the occipital zone. More than 6 hairs released in a single pull (about 10 percent of 60) across multiple zones supports active telogen effluvium.
A negative pull test does not rule out androgenetic alopecia: pattern miniaturization is not a "shedding more than normal" process, it is a "growing back thinner" process. So the test is most useful as a positive signal for telogen effluvium, not as a way to rule out pattern hair loss.
Step 3: 12 week photo cadence
| Week | Photo action | Read of the result |
|---|---|---|
| Week 0 | Baseline set: hairline, part, crown, both temples, occipital | Lock angle, distance, lighting, and dry-hair condition |
| Week 4 | Repeat full set under matched conditions | Confirm setup quality; trend reads are still too early |
| Week 8 | Repeat full set; add a wet-hair part photo | Diffuse density change supports telogen effluvium; patterned change supports androgenetic |
| Week 12 | Repeat full set; compare side by side with week 0 | Classify: improving (TE), stable (mixed), or worsening in pattern (AGA) |
See the telogen effluvium recovery tracking guide for the month 4 to 6 follow up that confirms a reversible shed.
Step 4: rule in the reversible drivers
Bloodwork is not optional in this workup. Ferritin, 25-hydroxyvitamin D, TSH, free T4, and a complete blood count catch the four most common reversible drivers that often coexist with pattern hair loss and can mimic an androgenetic trajectory if left uncorrected. The iron and ferritin protocol covers the iron workup in detail.
If trichoscopy is available through a dermatologist visit, the report can directly document hair diameter variability, follicular unit composition, and perifollicular signs. The trichoscopy report patient guide explains the terms a dermatologist will use.
Step 5: read the 12 week verdict
At week 12, use the photo set, the trigger map, the pull test history, and the lab results together. Three common outcomes.
Reading 1: clear telogen effluvium. Clear trigger 2 to 4 months before onset, positive pull across multiple zones, diffuse photo pattern, normal androgenetic exam, no progressive recession. Plan: address the trigger (iron, vitamin D, thyroid, stress, postpartum recovery), follow the 6 month recovery tracking guide, expect visible regrowth by month 4 to 6.
Reading 2: clear androgenetic alopecia. No clear trigger, negative or borderline pull, patterned photo change in the hairline, temples, crown, or central part, family history present. Plan: discuss finasteride or dutasteride, topical minoxidil, and a structured 6 to 12 month tracking plan to confirm response.
Reading 3: both at once. Clear trigger plus patterned thinning on the photo set, mixed labs. Plan: treat the reversible drivers, start a pattern-specific treatment on the dermatologist's advice, and track both layers separately so the 12 month review can attribute change correctly.
When to escalate sooner than 12 weeks
Three patterns warrant earlier dermatology contact rather than waiting for week 12: patchy hair loss with smooth bald areas (suggests alopecia areata, not the diffuse telogen pattern), scarring or scalp pain (suggests scarring alopecias such as frontal fibrosing alopecia or lichen planopilaris, which need specialist input quickly), and rapid hairline recession over weeks (unusual and worth a specialist read).
What "success" looks like at month 6 and month 12
A successful telogen effluvium outcome at month 6 shows shed counts back near baseline, short upright regrowth hairs visible at the part-line, and labs at target. By month 12, density on the central scalp is largely rebuilt and the pull test is negative.
A successful androgenetic alopecia outcome at month 6 shows shedding slowed (minoxidil early shed resolved), no further recession of the hairline, and the start of darker, thicker regrowth in the affected zones. By month 12, photo comparisons show preserved or improved density in the hairline, temples, and crown.
If neither outcome materializes by month 12, the workup needs to widen rather than repeat the same plan. Persistent diffuse shedding with normal labs may be chronic telogen effluvium and benefits from a different framing.
Sources: Headington JT 1993, Archives of Dermatology, "Telogen effluvium: new concepts and review". Olsen EA et al. 2005, Journal of the American Academy of Dermatology, "Evaluation and treatment of male and female pattern hair loss". Malkud S 2015, Journal of Clinical and Diagnostic Research, "Telogen effluvium: a review" (PMID 26500992).
Tell a stress shed apart from a pattern in 12 weeks of clean photos
BaldingAI runs a fixed-angle monthly photo record so a reversible shed and a progressive pattern look different on a timeline instead of being argued from memory.
Use the BaldingAI hair tracking app to save one baseline session now, compare monthly checkpoints later, and keep one clear record for your next treatment or dermatologist decision.
Use This Guide Well
For fundamentals content, the strongest signal is process quality: repeatable photos, stable scorecards, and comparable checkpoint windows.
- Use one primary metric set for all options you evaluate.
- Avoid switching frameworks mid-cycle, or your comparisons lose reliability.
- Commit to a checkpoint window and decide from trend direction, not one photo.
Safety note
This article is for education and tracking guidance. It does not replace diagnosis or treatment advice from a licensed clinician.
- Use matched photo conditions whenever possible.
- Review monthly trends instead of reacting to one photo day.
- Escalate persistent uncertainty or symptoms to clinician care.
Questions and Source Notes
How do I know if my treatment is working?
Compare monthly checkpoint photos taken under the same conditions. Look for these signals: reduced visibility of scalp through hair, maintained or improved hairline position, increased density in previously thin areas, and stabilization of previously active shedding. A treatment is working if it stops or slows further loss — regrowth is a bonus, not the only success metric. Give any treatment at least 6 months before evaluating.
When should I change or add to my current treatment?
If you have been consistent with a treatment for 6+ months and your tracking data shows continued decline, discuss adding a complementary treatment with your dermatologist. Do not change treatments based on a single bad photo or a few weeks of increased shedding. Decisions should come from trend data across multiple monthly checkpoints, not from day-to-day anxiety.
What does a dermatologist need to see at a follow-up?
Bring a visual timeline showing standardized photos from each monthly checkpoint, any density or coverage scores you have tracked, a log of treatment adherence (missed doses, dosage changes), and notes on side effects with dates. This turns a subjective conversation into an evidence-based review and helps your dermatologist make more precise adjustments.
Tell a stress shed apart from a pattern in 12 weeks of clean photos
BaldingAI runs a fixed-angle monthly photo record so a reversible shed and a progressive pattern look different on a timeline instead of being argued from memory.
Keep Reading From Here
Continue with the next article or matching tracking route that keeps this guide actionable instead of sending you back into broad browsing.
Next editorial reads
At-Home Hair Count Methods Compared in 2026
Decision Framework · awareness
Hair Density Apps Compared 2026: HairMetrix, TrichoLAB
Decision Framework · consideration
Vitamin D Deficiency and Hair Loss: What to Track
Foundational Guide · decision
Vitamin D Levels and Hair Loss: A Tracking Protocol
Foundational Guide · decision